Please assess the completion status of the following clinical trial:

Trial Title: Dosing of Ketorolac in the Emergency Department

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~\> 18 y/o~Exclusion Criteria:~pregnant allergic other contraindication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 0 mg (Type: PLACEBO_COMPARATOR): 0 mg ketorolac - placebo
- 10 mg (Type: ACTIVE_COMPARATOR): 10 mg ketorolac - low dose ketorolac
- 30 mg (Type: ACTIVE_COMPARATOR): 30 mg ketorolac - usual dose ketorolac

Based on this trial design, predict the completion outcome and termination type (if applicable).